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Gene regulation is mediated by site-speciﬁc DNA-binding proteins or transcription factors (TFs),
which form protein complexes at regulatory loci either to activate or repress the expression of a
target gene. The study of the dynamic properties of these regulatory DNA-binding complexes
has so far been dominated by protein-centered methodologies, aiming to characterize the
DNA-binding behavior of one speciﬁc protein at a time. With the emerging evidence for a role of
DNA in allosterically inﬂuencing DNA-binding protein complex formation, there is renewed
interest in DNA-centered approaches to capture protein complexes on deﬁned regulatory loci and
to correlate changes in their composition with alterations in target gene expression. In this review,
we present the current state-of-the-art in such DNA-centered approaches and evaluate recent
technological improvements in the puriﬁcation as well as in the identiﬁcation of regulatory
DNA-binding protein complexes within or outside their biological context. Finally, we suggest
possible areas of improvement and assess the putative impact of DNA-centered methodologies
on the gene regulation ﬁeld for the forthcoming years.
Why DNA-centered methods?
Diﬀerential gene expression is central to most fundamental
biological processes and is controlled by site-speciﬁc DNA
binding protein complexes. The latter transcriptional complexes,
of which transcription factors (TFs) are the core members,
function by integrating extra- and intracellular cues through
protein–protein or protein–ligand interactions and translating
these cues into a gene regulatory output by binding to gene
regulatory elements.1 Signal integration can thereby be
directly mediated by the TF itself, for example, through
post-translational modiﬁcation (PTM) of TF domains which
modulates its activity2 or cellular location,3 or can be con-
trolled indirectly through interaction with co-regulators. These
higher-order interactions can result in, or can also be the result
of PTMs, and can then determine whether the TF-containing
complex acts as an activator or repressor of gene expression.
This concept has perhaps been best characterized for nuclear
receptor TFs, for which multiple PTM-dependent co-activator
and co-repressor complexes have been identiﬁed (e.g. reviewed
in ref. 4 and 5). It is currently unclear to what extent these
higher-order protein interactions and resulting PTMs can
aﬀect DNA binding speciﬁcities and aﬃnities. Given that
TFs have often been observed to act both as activators and
repressors,4,6,7 it is possible that the associated DNA binding
complex inﬂuences DNA binding speciﬁcity or aﬃnity, for
example to distinguish genes that need to be repressed from
those that need to be activated. This could occur through
modulation not only of the TF DNA binding domain,8 but
also of regions located outside the DNA binding domain that
can alter DNA recognition and aﬃnity through protein
domain intercommunication.9–11 In recent years however,
there has been increasing evidence for the reverse notion of
the DNA dictating complex formation rather than the DNA
binding complex diﬀerentiating between gene targets.12–15 In
other words, while the implicated TF(s) is still responsible for
target gene identiﬁcation, the nucleotide composition of the
respective TF binding site allosterically inﬂuences co-regulator
recruitment and thus whether the resulting DNA binding
complex will activate or repress gene expression (Fig. 1). So
far, this phenomenon has been elucidated for only a couple of
TFs, including Oct-1,15 NFkB13 and glucocorticoid receptor,14
but it is possible that this regulatory principle extends to many,
if not most, other TFs. To validate this, it will be important
to perform a comprehensive analysis of transcriptional
complexes while bound to DNA, ideally without using
protein-speciﬁc antibodies as this would signiﬁcantly limit the
experimental scope since such antibodies are available for only
a low number of TFs and co-regulators. This DNA-centered
approach to transcriptional regulation would also allow
assessment of the dynamic properties of these complexes, as
the same ‘‘DNA bait’’ could be used in distinct biological
contexts. With the rapidly growing amount of experimentally
deﬁned regulatory element data (e.g. the Fantom and Encode
consortia16,17), there is a wealth of suitable DNA bait
candidates which could provide instrumental insights into gene
regulatory mechanisms. The use of actual regulatory elements
as DNA baits rather than TF binding site-representing double-
stranded oligonucleotides may thereby be more informative
given the often relatively poor correlation between in vitro-
derived TF binding sites and in vivo-observed binding events.18
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The practical realization of such DNA-centered analyses
has so far been diﬃcult, as there are inherent diﬃculties
associated with studying TF function such as their low
expression and involvement in many transient and context-
dependent interactions. Nevertheless, in recent years, important
experimental progress has been made, which promises to
signiﬁcantly improve our ability to study the dynamic properties
of transcriptional complexes in a DNA-centered fashion.
Here, we provide a critical overview of these advances by
highlighting their technical improvements over previously
available DNA-centered methods and by pinpointing the
remaining limitations. In addition, we brieﬂy compare
their output against protein-centered DNA binding complex
detection methods, and highlight the advantages and
disadvantages of each strategy.
DNA aﬃnity chromatography
General concept
The most familiar DNA-centered method is DNA aﬃnity
chromatography. This approach to study TF-containing
complexes is based on DNA bait-mediated protein puriﬁcation,
which is achieved by exploiting the inherent capacity of TFs to
bind to DNA. DNA is thereby either absorbed or linked
covalently to a chromatographic support before being used
for DNA aﬃnity chromatography. Originally, heterogeneous
non-speciﬁc DNA such as salmon or herring DNA was linked
to a cellulose or sepharose chromatographic support (reviewed
in ref. 19). This approach is not optimal for the puriﬁcation of
speciﬁc DNA binding complexes because of the abundant
prevalence of contaminant proteins which non-speciﬁcally
bind either to the support material or to the DNA. Rather,
this approach is now commonly used as one of the many
steps involved in TF puriﬁcation as it eﬃciently removes
contaminating proteins from complex protein mixtures. To
subsequently isolate selected TFs or DNA binding complexes,
speciﬁc DNA sequences are preferred. These are typically
double-stranded oligonucleotides either in single-copy or con-
catemerized format, which represent TF consensus binding
sites20 or very small DNA regions with known DNA binding
function identiﬁed, for example, through DNAse I footprinting.21
Since TFs have an aﬃnity several orders of magnitude greater
for their consensus binding site sequence compared to non-
speciﬁc DNA, the use of TF-speciﬁc double-stranded oligo-
nucleotides allows a relatively straightforward puriﬁcation of
the respective TF and associated proteins from complex
protein mixtures. However, this approach has also important
limitations. First, while binding site concatemerization
has been the preferred format for TF puriﬁcation, it also
introduces novel DNA sites, increasing the probability that
other proteins will bind to the DNA bait and thus reducing
purity.19 Second, DNA binding and complex assembly occurs
in vitro and since also stringent washing is required, only
proteins that bind with high aﬃnity to the respective TF will
be retained, making this approach not ideal to study the
dynamic properties of DNA binding complexes within their
endogenous context. Third, it requires prior knowledge of
speciﬁc TF binding sites. For a large number of TFs such
corresponding binding sites are still unavailable, limiting the
scope of this method.1 Consequently, the approach is
TF-centered, and will therefore not provide a comprehensive
view of the factors controlling the transcription of your gene
of interest. Fourth, such DNA bait typically represents just
one of the possible binding site possibilities. This is important
given the in vivo observation in both prokaryotic22 and
Fig. 1 Drawing illustrating the complex interplay between TF binding site recognition and DNA-binding protein complex formation at a speciﬁc
regulatory locus.
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eukaryotic systems1 that TFs also bind to sub-optimal binding
sites. Thus, while the use of high aﬃnity binding sites will
provide a signiﬁcant insight into DNA-binding protein
complexes involving the respective TF, it will be by no means
comprehensive. Moreover, it is becoming increasingly clear
that multiple binding sites with varying TF aﬃnities can
cooperate, for example through DNA looping, to stabilize
the TF-containing complex.23 Thus, individual sites would
fail to capture this complex. Finally, double-stranded oligo-
nucleotides or other short DNA fragments usually fail to
preserve the same DNA topology as that of the endogenously
occurring TF binding site, which has also been shown to aﬀect
DNA binding. For example, p53 binding to DNA was
enhanced with increasing negative superhelix density.24
Recent advances
In recent years, there have been attempts to overcome many
limitations by considering the use of single regulatory elements
(or at least short fragments thereof) such as enhancers or
promoters as DNA baits.25–28 This approach does not require
a priori knowledge of TF binding site properties, and since
elements are typically linked to a speciﬁc gene, it also provides
information of immediate relevance to how the respective gene
may be transcriptionally controlled. Recent examples of the
DNA aﬃnity chromatography approach include the isolation
of a Drosophila TF, DEAF-1, binding to the enhancer of an
immunity gene,26 as well as several proteins binding to
promoter fragments of, respectively, the human ESRRA and
MTA2 genes.27 In both studies, DNA was immobilized onto a
solid phase by biotin-labelling the DNA and coupling it to
either streptavidin-coated columns or magnetic beads. This is
in contrast with the technique of DNA trapping used by Jiang
and co-workers29 in which a 250 bp region of the human c-jun
promoter with a single stranded (GT)5 tail was annealed to
single-stranded (AC)5-Sepharose. Several pre-initiation
components such as RNA polymerase II, TBP, and the TFIF
subunit RAP 74 were retrieved as well as the TF SP1. DNA
trapping typically supports better puriﬁcation as streptavidin-
coated supports are known to bind to contaminating proteins
(Table 1). In addition, DNA trapping allows a non-denaturating
elution of bound proteins,29 which, because of the strength of
the interaction, is not possible with DNA immobilization
where high temperatures and denaturating agents such as
SDS are required to elute proteins. On the other hand, DNA
immobilization is less time consuming and amenable to
automatization due to its relatively simple workﬂow, and is
therefore often the method of choice. As indicated above, a
critical aspect of both techniques is the use of competitor
DNA such as salmon sperm DNA, poly(dI:dC) or scrambled
bait DNA to eliminate proteins that have low aﬃnity for the
DNA bait but would otherwise be retained because of the high
concentration of bait DNA.
DNA-binding protein identiﬁcation
Antibodies
The most straightforward and therefore widespread strategy
to identify captured TFs or TF-containing protein complex
members is based on the use of antibodies. Their application is
thereby not restricted to DNA aﬃnity chromatography,28 as
other protein–DNA interaction detection approaches also
beneﬁt greatly from antibody availability. An excellent
example is the supershift assay in which the identity of a
DNA-binding protein is conﬁrmed only when a protein-speciﬁc
antibody reduces the electrophoretic mobility of a protein–
DNA interaction complex.30 A signiﬁcant advantage of such a
gel shift procedure over other protein–DNA interaction
detection methods is its ability to distinguish single from
multimeric forms of bound protein and to immediately relate
this information to the respective DNA bait. For example,
using supershift assays, Tantin and colleagues31 determined
that DNA baits were more likely to induce di- or multi-
merization of the TF Oct-4 when they contained at least three
Oct-4 half sites. Thus, and as discussed already above, binding
site cooperativity can inﬂuence the formation of distinct TF
complex conﬁgurations, with each possibly having a diﬀerential
impact on how the respective target gene is transcriptionally
controlled. Nevertheless, despite their utility, antibodies
restrict the scope of the assay as only a limited number of
highly speciﬁc DNA-binding protein antibodies are currently
available. Moreover, antibody implementation requires an a
priori assumption about the identity of interacting proteins,
making this approach protein-centered. Thus, while several
protein-centered methods have already contributed in signiﬁcant
fashion to our understanding of the molecular mechanisms
underlying protein–DNA interactions in vitro and in vivo
(reviewed extensively in ref. 1), we will not discuss them here
given this review’s focus on DNA-centered protein–DNA
interaction approaches. Instead, we will brieﬂy discuss new
eﬀorts to eliminate the protein-centered bias of current DNA
bait-based techniques such as gel shift and DNA aﬃnity
chromatography by linking them to de novo protein detection
and identiﬁcation methods such as two-dimensional gel
electrophoresis (2-DE)32 and mass spectrometry.33 Since it is
desirable still to conﬁrm the identity of 2-DE-detected proteins
using mass spectrometry, we will brieﬂy focus on the latter
technology.
Mass spectrometry
Traditionally, the detection and identiﬁcation of DNA-binding
proteins or complexes by mass spectrometry has always been
diﬃcult owing to the low cellular abundance of the majority of
these types of proteins.34 In recent years, mass spectrometry
has become increasingly sensitive, driven by fast-paced
technological advances in instrumentation. This signiﬁcant
increase in mass accuracy and resolving power now allows
for the ﬁrst time a more detailed functional analysis of such
lowly expressed proteins as their spectral peaks become
increasingly distinguishable from background noise in com-
plex mixtures. Based on overall sensitivity, two mass analyzers
stand out. The ﬁrst is the Fourier transform ion cyclotron
resonance mass spectrometer (FT-ICR).35 The second is
the Orbitrap, which also uses an FT-based strategy.36 For
example, Mann and co-workers27 have used an FT-ICR to
identify sequence-speciﬁc DNA-binding proteins in HeLa S3
cells puriﬁed by DNA aﬃnity chromatography. Interestingly,
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when comparing the eluted protein SDS-PAGE proﬁles
from the wild-type and negative control DNA bait, there
was virtually no diﬀerence and thus no clear bands were
revealed corresponding to true speciﬁc DNA-binding proteins.
Nonetheless, because of the sensitivity of FT-ICR, candidate
DNA-binding proteins that were more abundant in the wild-
type versus negative control samples were in the end identiﬁed
(see also below). Protein-centered approaches aiming to
characterize TF-speciﬁc protein interaction partners or complexes
are also beneﬁting greatly from the recent sensitivity increase
as evidenced by the fact that many of the detected TF inter-
actors were themselves TFs.37,38 Thus, we are entering
an exciting era in which proteins such as TFs that have
traditionally been for the most part oﬀ-limit become increasingly
accessible and thus characterizable.
DNA-binding dynamics
To achieve a comprehensive, mechanistic understanding of
gene regulation, it is essential to not only determine the
identity of regulatory DNA-binding complex members, but
to also chart compositional complex changes in relation to
alterations in target gene expression. This need to monitor
protein complex assembly dynamics either with other proteins
or with DNA has prompted the development of quantitative
proteomics approaches (e.g. reviewed in ref. 39). The latter
involve the labelling of proteins with isotopically distinguishable
tags enabling a protein abundance comparison between two or
more biological samples. Brand et al.37 used isotope-coded
aﬃnity tagging (ICAT) to monitor the compositional changes
of the protein complex involving the TF NF-E2p18/MafK
during erythroid diﬀerentiation. Results uncovered more than
100 potential protein interactors and indicated that MafK acts
as a dual-function TF, exchanging dimerization partners upon
induction of diﬀerentiation, leading to the replacement of
interacting co-repressors with co-activators and up-regulation
of the expression of its target gene b-globin. To answer
questions related to the molecular mechanisms underlying this
protein partner exchange, the next step would be to monitor
the compositional changes of only those MafK-containing
complexes that are bound to DNA. Although this is in
principle feasible by monitoring the DNA occupation of
individual complex members at distinct time points using
chromatin immunoprecipitation,37,40 the unavailability of
antibodies for the majority of proteins limits, as indicated
previously, the scope of such assays and thus prevents a
functional analysis of the majority of detected protein inter-
action partners. Moreover, similar to other recent mass
spectrometry-based TF-protein interaction detection techniques
such as the streptavidin-mediated isolation of biotinylated TF
complexes,38 the approach used by Brand and colleagues37 is
again strictly TF or protein-centered and may therefore miss
crucial factors that may inﬂuence MafK complex assembly on
the DNA and thus b-globin gene regulation in general without
physically interacting with MafK, but for example by altering
DNA accessibility.41 With this experimental mindset, Mittler
et al.27 combined the ‘‘stable isotope labelling with amino
acids in cell culture’’ (SILAC) technique with DNA aﬃnity
chromatography to detect protein–DNA complex assembly
diﬀerences on wild-type versus mutated TF binding sites or
short regulatory element fragments. For both types of DNA
baits, a signiﬁcant number of putative binding proteins were
found. Since most of these were captured in approximately
equal amounts by the wild-type and negative control bait, they
could however be eliminated. The identity of the remaining
proteins was in line with predictions and proved the value
of their method. In addition, these researchers were able to
identify proteins, many of which were previously not
described, that preferentially bind to methylated versus non-
methylated CpG sites on theMTA2 gene promoter. While the
latter method clearly increases our ability to determine TF
binding proﬁles, it still suﬀers from the previously mentioned
important limitation that DNA binding and putative complex
assembly occurs in vitro and thus information regarding
Table 1 Summary of the strengths (+) and weaknesses () of the discussed DNA-centered methods to characterize regulatory protein–DNA
interaction complexes
Time-
consuming
Unambiguous
protein
puriﬁcation/
identiﬁcation
Unambiguous
complex
puriﬁcation/
identiﬁcation
Prone to
artiﬁcial
DNA
binding
Unbiased (truly
DNA-centered)
interaction screen
Protein complex
characterization
in its natural
context
Homogeneous
DNA
   
Heterogeneous
DNA
Short DNA
sequences
as DNA
bait
TF-speciﬁc double-
stranded oligo-
nucleotide trapping
 +  
TF-speciﬁc double-
stranded oligonucleotide
immobilization
+  
Concatemers +   
Long DNA
sequences
as DNA
bait
DNA trapping  + + + 
DNA
immobilization
+ + + 
PICh  + + + +
Supershift (Electrophoretic Mobility Super
Shift Assay)
 +    
High-throughput yeast one-hybrid +   
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the complex composition at the corresponding endogenous
locus is lost.
Alternative DNA-centered approaches
PICh
To enable the in vivo assessment of regulatory DNA-binding
complexes at speciﬁc gene loci, De´jardin and Kingston42 have
now developed the PICh (Proteomics of Isolated Chromatin
segments) method. This method is a drastic departure from
previous methods typically based on DNA aﬃnity chromato-
graphy as it is better described as a reverse chromatin
immunoprecipitation, since it uses cross-linking to ﬁx protein
complexes on DNA, but rather than using a protein-speciﬁc
antibody to identify bound DNA regions, it employs a DNA
element-speciﬁc probe to pull down the associated protein
complex (Fig. 2). The probe is an oligonucleotide containing
locked nucleic acid (LNA) residues. These have an altered
backbone that favours base stacking, thereby signiﬁcantly
increasing the stability of probe–DNA interactions. After the
probe has hybridized to chromatin cross-linked to protein
complexes, it is captured on streptavidin magnetic beads
through a desthiobiotin molecule covalently linked to the
probe. Desthiobiotin is a biotin analog with weaker aﬃnity
for avidin which therefore permits a more gentle competitive
elution using biotin, limiting the co-elution of non-speciﬁc
factors. Thus, by maintaining the DNA-bound protein
complex in its natural state and because probes can be
designed against any locus, PICh provides in principle the
possibility to correlate protein complex composition changes
with alterations in the expression of any target gene. However,
PICh has so far only been used to detect proteins associated
with human telomere sequences, which, with around
100 copies per cell, are rather abundant in the genome and
therefore compensate for the relatively low protein detection
Fig. 2 Drawing illustrating the protein complex puriﬁcation workﬂow using DNA aﬃnity chromatography (A) and PICh (B).
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sensitivity of the method. Evolving the method to allow
screening of less abundant chromatin loci or even unique
regulatory elements is now the next challenge and could
involve a reconsideration of probe design, the use of even
more sensitive mass spectrometers, or the integration of
quantitative proteomics techniques.
High-throughput yeast one-hybrid assay
While PICh has the promise to revolutionize the gene regulation
ﬁeld, it remains to be seen how much the method will live up to
expectations. Consequently, DNA aﬃnity chromatography as
well as other alternative methods will remain useful to study
the dynamic properties of regulatory DNA-binding complexes
in DNA-centered fashion. One other alternative method is the
high-throughput yeast one-hybrid system, which allows the
screening of regulatory elements of interest for interacting TFs
or TF dimers.43–45 Although the latter technique does not
allow the detection of DNA-binding complexes and is
performed in yeast and thus outside the endogenous context,
it provides the unique possibility to scan the whole regulatory
protein repertoire for binding to a DNA bait of choice
depending on the completeness of the screened TF library.46,47
Conclusion
In recent years, there has been renewed interest in obtaining a
complete understanding of the complex mechanisms underlying
gene regulation, driven by recent discoveries illustrating the
complex interplay between all components involved (DNA,
TFs, co-regulators etc.) in guiding the formation of functional
regulatory complexes, which either activate or repress gene
expression. Consequently, there are revived eﬀorts to improve
current technologies to enable an increasingly more accurate
and comprehensive study of gene regulatory complex formation.
Speciﬁcally, there is a signiﬁcant need to monitor the formation
of such complexes at deﬁned regulatory loci in distinct bio-
logical contexts, hence the renewed interest in DNA-centered
protein–DNA interaction detection technologies. Although
progress in this area has been made as discussed in this review,
we are still far from the complete and functional characterization
of DNA-binding protein complexes and from the ability to
relate changes in their composition to expression changes of
their respective target genes. In this regard, we are eagerly
looking forward to novel developments in the in vivo quantitative
proteomics ﬁeld, to improved TF and protein complex
puriﬁcation methods, and to further increases in the sensitivity
of mass spectrometers, which are quickly becoming the ‘‘gold
standard’’ in the analysis of DNA-binding functional protein
complexes.
Abbreviations
TF Transcription Factor
PTM Post-Translational Modiﬁcation
SDS Sodium Dodecyl Sulfate
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis
2-DE Two-dimensional Gel Electrophoresis
FT Fourier Transform
FT-ICR Fourier Transform Ion Cyclotron Resonance
ICAT Isotope-Coded Aﬃnity Tags
SILAC Stable Isotope Labelling with Amino Acids in
Cell Culture
PICh Proteomics of Isolated Chromatin Segments
LNA Locked Nucleic Acid
Co-R Co-regulatory element
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